BPC157 is not FDA-approved for human use in the United States
Typical dosage: 250500mcg once or twice daily Administration: Subcutaneous or intramuscular injection near the injury site Cycle length: 24 weeks for minor injuries
Zhao W-J, Wang K
BPC-157 is studied for protective and signaling mechanisms: shielding cells from damage, reducing excessive inflammation, and promoting growth factor activity
Components: NAD+, high-dose Vitamin C, B complex, magnesium, zinc, glutathione Best for: brain fog, fatigue, shortness of breath, immune dysregulation post-infection Duration: 2.53 hours Immune Boost Bundle (Signature TRAAC Protocol) $300 Your branded entry-level immune drip
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit